95 related articles for article (PubMed ID: 20629325)
1. [Effect of glucagon-like peptide-2 (GLP-2) on intestinal barrier function in bile duct ligated rats].
Ge PL; Li N; Jia QB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 May; 41(3):476-9. PubMed ID: 20629325
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide-2 protects impaired intestinal mucosal barriers in obstructive jaundice rats.
Chen J; Dong JT; Li XJ; Gu Y; Cheng ZJ; Cai YK
World J Gastroenterol; 2015 Jan; 21(2):484-90. PubMed ID: 25593463
[TBL] [Abstract][Full Text] [Related]
3. [Effect of ulinastatin on intestinal mucosal barrier function of rats with obstructive jaundice].
Tian YF; Li Y; Zhao Q; Fan LQ; Zhao WJ; Xu BL; Song ZC; Kuang G; Dong ZM; Zhang QF
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):987-90. PubMed ID: 17666333
[TBL] [Abstract][Full Text] [Related]
4. Obstructive jaundice alters proliferating cell nuclear antigen expression in rat small intestine.
Sheen-Chen SM; Ho HT; Chen WJ; Eng HL
World J Surg; 2003 Oct; 27(10):1161-4. PubMed ID: 12917765
[TBL] [Abstract][Full Text] [Related]
5. Glucagonlike peptide 2 protects intestinal barrier in severe acute pancreatitis through regulating intestinal epithelial cell proliferation and apoptosis.
Chen X; Zhao HX; Fu XS; Li CP; Zhong XL
Pancreas; 2012 Oct; 41(7):1080-5. PubMed ID: 22481288
[TBL] [Abstract][Full Text] [Related]
6. [The protective effect of recombinant glucagons like peptide-2 on intestinal mucosa of burn rats].
Zhao Y; Wang FJ; Wang P; Chen Y; Wang SL
Zhonghua Shao Shang Za Zhi; 2007 Aug; 23(4):253-6. PubMed ID: 18095546
[TBL] [Abstract][Full Text] [Related]
7. [Influence of glucagon-like peptide-2 on the proliferation of the intestinal mucosal cells in scalded rats].
Zhao Y; Wang FJ; Wang P; You ZY; Peng X; Wang SL
Zhonghua Shao Shang Za Zhi; 2003 Aug; 19(4):209-12. PubMed ID: 14514399
[TBL] [Abstract][Full Text] [Related]
8. GLP-2 Prevents Intestinal Mucosal Atrophy and Improves Tissue Antioxidant Capacity in a Mouse Model of Total Parenteral Nutrition.
Lei Q; Bi J; Wang X; Jiang T; Wu C; Tian F; Gao X; Wan X; Zheng H
Nutrients; 2016 Jan; 8(1):. PubMed ID: 26761030
[TBL] [Abstract][Full Text] [Related]
9. [Effects of glucagon-like peptide 2 on the adaptation of residual small bowel in a rat model of short bowel syndrome].
Wu GH; Chen J; Li H; Wu ZH
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):441-4. PubMed ID: 17043970
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome.
Martin GR; Wallace LE; Sigalet DL
Am J Physiol Gastrointest Liver Physiol; 2004 Jun; 286(6):G964-72. PubMed ID: 14962847
[TBL] [Abstract][Full Text] [Related]
11. Effect of Danshen on apoptosis and NF-κB protein expression of the intestinal mucosa of rats with severe acute pancreatitis or obstructive jaundice.
Zhang XP; Jiang J; Yu YP; Cheng QH; Chen B
Hepatobiliary Pancreat Dis Int; 2010 Oct; 9(5):537-46. PubMed ID: 20943465
[TBL] [Abstract][Full Text] [Related]
12. Synergy of glucagon-like peptide-2 and epidermal growth factor coadministration on intestinal adaptation in neonatal piglets with short bowel syndrome.
Lim DW; Levesque CL; Vine DF; Muto M; Koepke JR; Nation PN; Wizzard PR; Li J; Bigam DL; Brubaker PL; Turner JM; Wales PW
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G390-G404. PubMed ID: 28104586
[TBL] [Abstract][Full Text] [Related]
13. The intestinal epithelial insulin-like growth factor-1 receptor links glucagon-like peptide-2 action to gut barrier function.
Dong CX; Zhao W; Solomon C; Rowland KJ; Ackerley C; Robine S; Holzenberger M; Gonska T; Brubaker PL
Endocrinology; 2014 Feb; 155(2):370-9. PubMed ID: 24265452
[TBL] [Abstract][Full Text] [Related]
14. [Protective effects of glucagon-like peptide 2 on intestinal ischemia/reperfusion injury in mice].
Guan LL; Gong DZ; Tian N; Zou Y
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 May; 21(2):192-4. PubMed ID: 21171341
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of glucagon-like peptide 2 on intestinal ischemia-reperfusion rats.
Zhang W; Zhu W; Zhang J; Li N; Li J
Microsurgery; 2008; 28(4):285-90. PubMed ID: 18383347
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-Like Peptide-2 Improve Intestinal Mucosal Barrier Function in Aged Rats.
Ren W; Wu J; Li L; Lu Y; Shao Y; Qi Y; Xu B; He Y; Hu Y
J Nutr Health Aging; 2018; 22(6):731-738. PubMed ID: 29806863
[TBL] [Abstract][Full Text] [Related]
17. Is OM-3 synergistic with GLP-2 in intestinal failure?
Karmaker A; Costanzo CM; Schwartz MZ
J Surg Res; 2017 Jan; 207():7-12. PubMed ID: 27979490
[TBL] [Abstract][Full Text] [Related]
18. Evidence for intestinal oxidative stress in obstructive jaundice-induced gut barrier dysfunction in rats.
Assimakopoulos SF; Vagianos CE; Patsoukis N; Georgiou C; Nikolopoulou V; Scopa CD
Acta Physiol Scand; 2004 Feb; 180(2):177-85. PubMed ID: 14738476
[TBL] [Abstract][Full Text] [Related]
19. Bombesin and neurotensin reduce endotoxemia, intestinal oxidative stress, and apoptosis in experimental obstructive jaundice.
Assimakopoulos SF; Scopa CD; Zervoudakis G; Mylonas PG; Georgiou C; Nikolopoulou V; Vagianos CE
Ann Surg; 2005 Jan; 241(1):159-67. PubMed ID: 15622004
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats.
Washizawa N; Gu LH; Gu L; Openo KP; Jones DP; Ziegler TR
JPEN J Parenter Enteral Nutr; 2004; 28(6):399-409. PubMed ID: 15568286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
